30.10.2013 Views

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Genomics, technology, bioinformatics<br />

Leiden, The Netherlands, 5 Erasmus MC, Rotterdam, The Netherlands.<br />

The panoply of human globin gene mutation detection methods has become<br />

significantly enriched with the advent of microarray-based genotyping<br />

platforms. So far, a handful of microarray-based methods have<br />

been described for mutation screening in the human globin genes region,<br />

namely a microelectronic array, arrayed primer extension-based<br />

(APEX) systems and microarrays involving tagged single-base extension<br />

(SBE) with hybridization to universal glass microarrays. We report<br />

here a new flow-through microarray for human β-globin gene mutation<br />

detection. This microarray has a porous surface and uses Al 2 O 3 as<br />

a solid support, which allows not only diffusion-independent binding<br />

kinetics, but also monitoring of hybridization of the extended primers<br />

in real-time by repeated cycling of the sample through the array. The<br />

hybridization process is therefore fully reaction-rate limited and completed<br />

within a few minutes. The microarray is read by a dedicated<br />

instrument (PamStation TM ), while data are analyzed using specialized<br />

software. The microarray is being developed to screen for both causative<br />

β-globin gene mutations leading to β-thalassemia and associated<br />

SNPs for haplotype analysis. For this reason, 20 different β-globin<br />

gene mutations and 15 SNPs located in the human β-globin locus can<br />

be currently addressed using this platform (Phase I) with the ultimate<br />

goal to expand the microarray’s capacity to screen for a total of 108<br />

causative mutations and 30 SNPs (Phase II). Taken together the low<br />

analysis costs (i.e. 50-70€ per patient), this platform might develop into<br />

an option for numerous potential applications from human molecular<br />

diagnostics to pre-implantation genetic diagnosis and non-invasive<br />

prenatal diagnosis of hemoglobinopathies.<br />

P1274. Microarray analysis of bone metabolism genes in<br />

patients with osteoporosis<br />

D. N. Ghorab 1 , M. V. Moskalenko 1 , A. S. Glotov 2 , E. S. Vashukova 2 , L. B. Polushkina<br />

2 , T. E. Ivaschenko 2 , M. V. Assev 2 , V. G. Pinelis 3 , V. S. Baranov 2 ;<br />

1 Saint-Petersburg State University, Saint-Petersburg, Russian Federation, 2 Ott’s<br />

Institute of Obstetrics & Gynecology RAMS, Saint-Petersburg, Russian Federation,<br />

3 Scientific Center of Children Health RAMS, Moscow, Russian Federation.<br />

Osteoporosis is a complex desease with a strong genetic component.<br />

Various genes encoding bone associated proteins, cytokines and receptors,<br />

have been shown to contribute to genetic basis of the disease.<br />

For analysis following loci were selected: Col1a1 (-<strong>19</strong>97 G/T, 1245 G/<br />

T), BGP (-<strong>19</strong>8 C/T), IL-6 (-174 C/T), TNFα (-308 G/A), VDR (-3731<br />

A/G, 6<strong>19</strong>68 C/T), ER (36627 C/T, 36673 A/G) and GR (N363S A/G).<br />

These loci feature significant genetic polymorphism, and are thought<br />

to be associated with genetic predisposition to osteoporosis. A genetic<br />

study of predisposition to the osteoporosis is believed to extend our<br />

knowledge about the disease and to determine the optimal terms for<br />

antiosteoporotic therapies.<br />

We have started to introduce in practice a new molecular approach,<br />

developed with using of multiplex PCR followed by allele-specific hybridization<br />

on biochip for SNPs detection. Amplified DNA with fluorescent<br />

labels was hybridized with oligonucleotide DNA probes immobilized<br />

in gel pads on a biochip. The efficiency of the protocol was tested<br />

in our laboratory. The results showed 100% concordance between the<br />

biochip-based approach and the established PCR protocol.<br />

The genotyping procedure, which is faster, reliable and can be used for<br />

rapid screening on the biochip is suggested for the analysis of genetic<br />

predisposition to multifactorial diseases, including osteoporosis.<br />

P1275. A new method for separation and characterization of<br />

small RNA by On-Chip Electrophoresis<br />

R. Salowsky1 , C. Tissot1 , M. Valer2 , Y. Filaudeau3 ;<br />

1 2 Agilent Technologies, Waldbronn, Germany, Agilent Technologies, Inc., Santa<br />

Clara, CA, United States, 3Agilent Technologies, Nice, France.<br />

MicroRNAs have just been recognized to play important roles in regulation<br />

in the genomes of animals and plants. To understand and describe<br />

their functional roles many questions still have to be answered.<br />

A major drawback for current experiments is the lack of adequate analytical<br />

methods for the analysis of small RNA samples and understanding<br />

on how RNA integrity and different purification protocols affect its<br />

qualitative and quantitative analysis.<br />

Here we describe a novel Microfluidic assay that is able to perform<br />

very sensitive high resolution analyses of small RNA samples on a<br />

commercial lab-on-a-chip platform commonly used for RNA QC analysis.<br />

The assay delivers information about size and concentration of<br />

small RNA species like miRNA, siRNA, t-RNA etc, in the range from<br />

10 to 150nt. Purified or enriched small RNA fractions, as well as total<br />

RNA samples with miRNA concentrations down to 50 pg/µl can be<br />

analyzed.<br />

Verification of quality and quantity of miRNA after extraction protocols<br />

is a major application for this Assay. Capability for separation and efficient<br />

detection of both single- and double strand nucleic acids widens<br />

the range for sensitive analysis with this On-Chip assay.<br />

P1276. Functional assessment of DNA loop repair in human<br />

nuclear extracts<br />

S. Jaroudi, J. C. Harper, S. B. SenGupta;<br />

University College London, London, United Kingdom.<br />

Introduction: Mismatch repair (MMR) corrects small base mismatches<br />

and insertion/deletion loops that arise within microsatellite repeats.<br />

Current repair assays predominantly rely on cloning techniques. We<br />

have designed an alternative functional assay for MMR.<br />

Methods: Heteroduplex DNA molecules containing an insertion loop<br />

were created by hybridisation of purified complementary single strands<br />

of DNA from PCR products of the DMPK1 trinucleotide repeat locus<br />

from separate homozygous samples. A nick was introduced 5’ to the<br />

heterology to direct the repair to a specific strand. Heteroduplex constructs<br />

were exposed to nuclear extracts from HeLa (MMR efficient)<br />

and LoVo (MSH2 deficient) cells to repair the insertion loop. Using<br />

semi-quantitative fluorescence analysis, the ratio of fluorescence from<br />

the nicked strand and the complementary un-nicked strand could be<br />

determined (R-value). Repair efficiency was assessed by comparing<br />

R-values before and after exposure to nuclear extracts.<br />

Results: Exposure of heteroduplexes to HeLa nuclear extracts resulted<br />

in change in the R-value, indicative of repair. Repair was independent<br />

of loop size (2, 21 and 24-bases) and nick directed. Little or no<br />

repair was detected for 2-base loops in absence of a 5’-nick, however,<br />

for larger loops repair was nick independent. Change in the R-value<br />

was proportional to the duration of exposure to nuclear extracts. LoVo<br />

nuclear extracts showed little repair for large loops and no repair was<br />

detected for the 2-base loops.<br />

Conclusion: This construct is easily generated and modified to vary the<br />

size of the insertion loop. The same approach can be used to assess<br />

repair of base-base mismatches.<br />

P1277. The mitochondrial DNA content per cell in human cord<br />

blood leukocytes gradually decreases during gestation<br />

M. Pejznochova, M. Tesarova, T. Honzik, H. Hansikova, M. Magner, J. Zeman;<br />

Dept. of Pediatrics, Faculty of Medicine, Charles University, Prague, Czech<br />

Republic.<br />

Most diseases in premature neonates are secondary to immaturity of<br />

various organ systems. In addition, the inadequate capacity of mitochondrial<br />

energy production may play an important role in the neonatal<br />

morbidity. Isolated human cord blood leukocytes (HCBL) contribute<br />

very little to the overall metabolic turnover, but they may serve as easily<br />

available marker cells for studying the changes of mtDNA amount<br />

during fetal development. Therefore the aim of our study was to analyze<br />

the amount of mitochondrial DNA in HCBL during the gestation.<br />

HCBL were isolated from blood samples of 107 neonates born between<br />

25 th and 41 st week of gestation. Blood samples were obtained<br />

after the delivery from placental part of umbilical cord. The mtDNA<br />

amount was analyzed by the real-time PCR method on the instrument<br />

Chromo4 (Bio-Rad) using SybrGreen I.<br />

The significant negative correlations were found between the relative<br />

mtDNA amount in HCBL and gestational age (r = - 0,54; p < 0,01) and<br />

birth weight (r = - 0,43; p < 0,01), respectively.<br />

The results revealed that the mtDNA content per cell decreases in<br />

HCBL with onward fetal development. This may be explained by gradual<br />

shift of the hematopoiesis from fetal liver to bone marrow during the<br />

second half of pregnancy presumably accompanied by decreasing cell<br />

volume of HCBL as it was shown similarly in red blood cells.<br />

This work was supported by grant GACR 303/03/H065.<br />

1

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!